Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
STABILIZED RADIOPHARMACEUTICAL COMPOSITION
Document Type and Number:
WIPO Patent Application WO/2023/100852
Kind Code:
A1
Abstract:
The purpose of the present invention is to provide a stabilized radiopharmaceutical composition wherein the decrease in the radiochemical purity over time is suppressed even in the case where the radioactivity concentration is high immediately after manufacture. The present invention pertains to a stabilized radiopharmaceutical composition that comprises, as an active ingredient, a polypeptide labeled with a radionuclide and having a group selected from the group consisting of thioether and thiol groups, a solubilizing agent having an ethylene glycol group, a solvent containing water, and a stabilizing agent selected from the group consisting of a sulfur-containing amino acid or salt thereof, a sulfur-containing amino acid derivative or salt thereof and a polysaccharide.

Inventors:
ICHIKAWA HIROAKI (JP)
NAKAMURA SHUNSUKE (JP)
TSUSHIMA MICHIHIKO (JP)
SATO TAKUMI (JP)
KISHIMOTO SATOSHI (JP)
OTSUKA YUTA (JP)
Application Number:
PCT/JP2022/043913
Publication Date:
June 08, 2023
Filing Date:
November 29, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
NIHON MEDIPHYSICS CO LTD (JP)
International Classes:
A61K47/10; A61K51/08; A61K47/20; A61K47/26; A61K47/36; A61P43/00
Domestic Patent References:
WO2020021322A12020-01-30
WO2021052960A12021-03-25
WO2008009444A12008-01-24
WO2020075746A12020-04-16
WO2011147762A22011-12-01
WO2021033530A12021-02-25
Foreign References:
JP2006528644A2006-12-21
Attorney, Agent or Firm:
KAMADA, Mitsunori et al. (JP)
Download PDF: